Retirement of Louis-Gilles Durand, IRCM’s Vice President, Administration and Finance

Sept. 28 2018 | Internal community

All news

The Montreal Clinical Research Institute (IRCM) recently highlighted the retirement of Louis-Gilles Durand, Vice President, Administration and Finance, after a career spanning more than 43 years at the IRCM.

Louis-Gilles Durand holds a bachelor's degree in electrical engineering (1975) and a master's degree in biomedical engineering (1979) from Polytechnique Montréal, as well as a PhD in biomedical engineering (1983) from Université de Montréal. He first joined the IRCM in 1975 to set up a medical electronics laboratory, which a few years later became the Biomedical Engineering Research Unit and pursued its activities until it closed in 2010. He has extensive expertise in the development of instruments and methods that can be used to assess cardiovascular and pulmonary disorders. Dr. Durand is an Officer of the Ordre national du Québec. He has trained a large number of engineers and scientists, and is the author of over 300 articles.

In addition to his scientific career, Dr. Durand has held several administrative positions at the IRCM, including the role of Interim President and Scientific Director from 2004 to 2006, as well as the treasurer of the IRCM and its foundation. He has also actively contributed to the IRCM Foundation's Ambassadors’ Committee.

“Throughout his career–first as a researcher, then as a manager–Dr. Durand has been an essential asset to the Institute's development. I am very grateful to him for these decades of commitment to science and to the Institute’s management,” said Tarik Möröy, President and Scientific Director of the IRCM. “On behalf of the IRCM community, I would like to thank him for his many years of loyal service and wish him a happy and well-deserved retirement.”

Paul Robert, Vice President, Legal Affairs and Technology Transfer, and Secretary General, will act as Vice President of Administration and Finance until the appointment of Dr. Durand’s successor.